Barclays maintains Amneal Pharmaceuticals at Overweight
Barclays is maintaining its Overweight rating on Amneal Pharmaceuticals, according to Benzinga ratings actions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.